Therapeutic Treatment of Arthritic Mice with 15-Deoxy Δ12,14-Prostaglandin J2 (15d-PGJ2) Ameliorates Disease through the Suppression of Th17 Cells and the Induction of CD4+CD25-FOXP3+ Cells.
about
Therapeutic Treatment of Arthritic Mice with 15-Deoxy Δ12,14-Prostaglandin J2 (15d-PGJ2) Ameliorates Disease through the Suppression of Th17 Cells and the Induction of CD4+CD25-FOXP3+ Cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 October 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Therapeutic Treatment of Arthr ...... tion of CD4+CD25-FOXP3+ Cells.
@en
Therapeutic Treatment of Arthr ...... tion of CD4+CD25-FOXP3+ Cells.
@nl
type
label
Therapeutic Treatment of Arthr ...... tion of CD4+CD25-FOXP3+ Cells.
@en
Therapeutic Treatment of Arthr ...... tion of CD4+CD25-FOXP3+ Cells.
@nl
prefLabel
Therapeutic Treatment of Arthr ...... tion of CD4+CD25-FOXP3+ Cells.
@en
Therapeutic Treatment of Arthr ...... tion of CD4+CD25-FOXP3+ Cells.
@nl
P2860
P50
P356
P1476
Therapeutic Treatment of Arthr ...... ction of CD4+CD25-FOXP3+ Cells
@en
P2093
Larissa G Pinto
Thiago M Cunha
P2860
P304
P356
10.1155/2016/9626427
P50
P577
2016-10-31T00:00:00Z